Skip to main content
Equibles

Balyasny Asset Management L.P.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1218710 Chicago, IL
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$894,134
-$4,130,304 QoQ
Shares Held
61,707
-81.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 238 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. RDY ranks #14 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LNTH
Lantheus Holdings, Inc.
 277,821 $30,821,461
2 KNSA
Kiniksa Pharmaceuticals International, plc
 309,682 $19,804,163
3 BIOA
BioAge Labs, Inc.
 702,858 $17,227,049
4 AMLX
Amylyx Pharmaceuticals, Inc.
 684,974 $12,302,133
5 TAK
Takeda Pharmaceutical Co Ltd
 511,336 $8,196,716
6 HIMS
Hims & Hers Health, Inc.
 218,958 $7,591,273
7 AMRX
Amneal Pharmaceuticals, Inc.
 434,132 $7,514,824
8 ALKS
Alkermes plc.
 142,366 $7,459,978

All Filings in RDY

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $894,134 61,707
2025-06-30 $5,024,438 334,294
2024-12-31 $1,639,791 103,850
2024-09-30 $935,841 11,779
2024-03-31 $1,127,976 15,378
2023-12-31 $510,508 7,337
2023-09-30 $916,988 13,713
2023-06-30 $1,076,404 17,056
2022-09-30 $300,745 5,746